No variable specified
Northside qualifies for cancer project, picked for partnership
by Staff Reports
December 06, 2013 06:27 PM | 2256 views | 0 0 comments | 33 33 recommendations | email to a friend | print
The Fort Washington, Pa.-based National Comprehensive Cancer Network Affiliate Research Project, developed by the network’s Oncology Research Program, last week announced it has qualified the Northside Hospital Cancer Institute in Sandy Springs for the project.

The institute is a community-based associate of the University of Alabama at Birmingham Comprehensive Cancer Center — one of the 23 network member institutions.

“The newly established collaboration between NCCN and Northside Hospital Cancer Institute will benefit both pa-tients and investigators involved in NCCN ORP-funded clinical trials,” said Diane Paul, MS, RN, vice president of the network’s Oncology Research program. “NCCN is excited to welcome Northside Hospital Cancer Institute as the new-est affiliate in this landmark project.”

Located in Sandy Springs with 33 satellite facilities across Georgia, the institute is operating as an network Affiliate Research Program site under the leadership of Guilherme Cantuaria, MD, PhD, medical director and principal investi-gator, NCI Community Cancer Center Program at Northside Hospital Cancer Institute, and is the 10th community-based network member institution affiliate to quality for the Affiliate Research, increasing the scope of potential patients for the more than 75 actively accruing Oncology Research Program clinical trials. The institute joins Medical Center of Central Georgia in representing the University of Alabama at Birmingham Comprehensive Cancer Center as a community-based affiliate in the project.

In other news, Northside’s Blood and Marrow Transplant Program, the only program in Georgia and just one of 10 in the country, was selected to participate in the prestigious and groundbreaking Blood Cancer Research Partnership, established by the Dana-Farber Cancer Institute in Boston and the Leukemia & Lymphoma Society, the hospital announced Friday.

This partnership is a network of sites for clinical trial testing of innovative blood cancer therapies in community oncology settings across the country. It brings clinical trials closer to where patients live and helps address one of the primary bottlenecks in the development of new cancer therapies: the need for more patients to take part in trials.

The Northside program is one of the largest and most comprehensive programs in the nation, serving patients who require bone marrow or stem cell transplants and providing primary leukemia treatment. An accomplished group of nationally recognized physicians, along with a team of highly trained professionals, spearhead the amazing work that takes place at Northside. In 2013, the National Marrow Donor Program reported the hospital as having among the best survival outcomes in the country for related and unrelated bone marrow transplants for the fourth consecutive year.

Information: www.NCCN.org/patients or www.northside.com.
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
*We welcome your comments on the stories and issues of the day and seek to provide a forum for the community to voice opinions. All comments are subject to moderator approval before being made visible on the website but are not edited. The use of profanity, obscene and vulgar language, hate speech, and racial slurs is strictly prohibited. Advertisements, promotions, spam, and links to outside websites will also be rejected. Please read our terms of service for full guides